1
|
Shah TA, Zhu Y, Shaikh NN, Harris MA, Harris SE, Rogers MB. Characterization of new bone morphogenetic protein (Bmp)-2 regulatory alleles. Genesis 2017; 55. [PMID: 28401685 DOI: 10.1002/dvg.23035] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/23/2016] [Revised: 03/16/2017] [Accepted: 04/06/2017] [Indexed: 12/28/2022]
Abstract
Bone morphogenetic protein 2 (BMP2, HGNC:1069, GeneID: 650) is a classical morphogen; a molecule that acts at a distance and whose concentration influences cell proliferation, differentiation, and apoptosis. Key events requiring precise Bmp2 regulation include heart specification and morphogenesis and neural development. In mesenchymal cells, the concentration of BMP2 influences myogenesis, adipogenesis, chondrogenesis, and osteogenesis. Because the amount, timing, and location of BMP2 synthesis influence pattern formation and organogenesis, the mechanisms that regulate Bmp2 are crucial. A sequence within the 3'UTR of the Bmp2 mRNA termed the "ultra-conserved sequence" (UCS) has been largely unchanged since fishes and mammals diverged. Cre-lox mediated deletion of the UCS in a reporter transgene revealed that the UCS may repress Bmp2 in proepicardium, epicardium, and epicardium-derived cells (EPDC) and in tissues with known epicardial contributions (coronary vessels and valves). The UCS also repressed the transgene in the aorta, outlet septum, posterior cardiac plexus, cardiac and extra-cardiac nerves, and neural ganglia. We used homologous recombination and conditional deletion to generate three new alleles in which the Bmp2 3'UTR was altered as follows: a UCS flanked by loxP sites with or without a neomycin resistance targeting vector, or a deleted UCS. Deletion of the UCS was associated with elevated Bmp2 mRNA and BMP signaling levels, reduced fitness, and embryonic malformations.
Collapse
Affiliation(s)
- Tapan A Shah
- Department of Microbiology, Biochemistry, and Molecular Genetics, Rutgers NJMS, Newark, New Jersey
| | - Youhua Zhu
- Department of Microbiology, Biochemistry, and Molecular Genetics, Rutgers NJMS, Newark, New Jersey
| | - Nadia N Shaikh
- Department of Microbiology, Biochemistry, and Molecular Genetics, Rutgers NJMS, Newark, New Jersey
| | - Marie A Harris
- Department of Periodontics, University of Texas Health Science Centre, San Antonio, Texas
| | - Stephen E Harris
- Department of Periodontics, University of Texas Health Science Centre, San Antonio, Texas
| | - Melissa B Rogers
- Department of Microbiology, Biochemistry, and Molecular Genetics, Rutgers NJMS, Newark, New Jersey
| |
Collapse
|
2
|
Fotinos A, Fritz DT, Lisica S, Liu Y, Rogers MB. Competing Repressive Factors Control Bone Morphogenetic Protein 2 (BMP2) in Mesenchymal Cells. J Cell Biochem 2016. [PMID: 26212702 DOI: 10.1002/jcb.25290] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
Abstract
The amount, timing, and location of bone morphogenetic protein 2 (BMP2) synthesis influences the differentiation of pluripotent mesenchymal cells in embryos and adults. The BMP2 3'untranslated region (3'UTR) contains a highly conserved AU-rich element (ARE) embedded in a sequence that commonly represses gene expression in mesenchymal cells. Computational analyses indicate that this site also may bind several microRNAs (miRNAs). Although miRNAs frequently target AU-rich regions, this ARE is unusual because the miRNAs directly span the ARE. We began to characterize the factors that may regulate Bmp2 expression via this complex site. The activating protein HuR (Hu antigen R, ELAVL1, HGNC:3312) directly binds this ARE and can activate gene expression. An miRNA was demonstrated to reverse HuR-mediated activation. Mutational and RNA-interference evidence also supports an AUF1 (AU-factor-1, HNRNPD, HGNC:5036) contribution to the observed repressive activity of the 3'UTR in mesenchymal cells. A limited number of studies describe how miRNAs interact with ARE-binding proteins that bind adjacent sites. This study is among the first to describe protein/miRNA interactions at the same site.
Collapse
Affiliation(s)
- Anastasios Fotinos
- Department of Microbiology, Biochemistry and Molecular Genetics, Rutgers New Jersey Medical School, Newark, New Jersey
| | - David T Fritz
- Department of Microbiology, Biochemistry and Molecular Genetics, Rutgers New Jersey Medical School, Newark, New Jersey
| | - Steven Lisica
- Department of Microbiology, Biochemistry and Molecular Genetics, Rutgers New Jersey Medical School, Newark, New Jersey
| | - Yijun Liu
- Department of Microbiology, Biochemistry and Molecular Genetics, Rutgers New Jersey Medical School, Newark, New Jersey
| | - Melissa B Rogers
- Department of Microbiology, Biochemistry and Molecular Genetics, Rutgers New Jersey Medical School, Newark, New Jersey
| |
Collapse
|
3
|
Rogers MB, Shah TA, Shaikh NN. Turning Bone Morphogenetic Protein 2 (BMP2) on and off in Mesenchymal Cells. J Cell Biochem 2016; 116:2127-38. [PMID: 25776852 DOI: 10.1002/jcb.25164] [Citation(s) in RCA: 42] [Impact Index Per Article: 5.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/05/2015] [Accepted: 03/10/2015] [Indexed: 01/26/2023]
Abstract
The concentration, location, and timing of bone morphogenetic protein 2 (BMP2, HGNC:1069, GeneID: 650) gene expression must be precisely regulated. Abnormal BMP2 levels cause congenital anomalies and diseases involving the mesenchymal cells that differentiate into muscle, fat, cartilage, and bone. The molecules and conditions that influence BMP2 synthesis are diverse. Understandably, complex mechanisms control Bmp2 gene expression. This review includes a compilation of agents and conditions that can induce Bmp2. The currently known trans-regulatory factors and cis-regulatory elements that modulate Bmp2 expression are summarized and discussed. Bone morphogenetic protein 2 (BMP2, HGNC:1069, GeneID: 650) is a classical morphogen; a molecule that acts at a distance and whose concentration influences cell behavior. In mesenchymal cells, the concentration of BMP2 influences myogenesis, adipogenesis, chondrogenesis, and osteogenesis. Because the amount, timing, and location of BMP2 synthesis influence the allocation of cells to muscle, fat, cartilage, and bone, the mechanisms that regulate the Bmp2 gene are crucial. Key early mesodermal events that require precise Bmp2 regulation include heart specification and morphogenesis. Originally named for its osteoinductive properties, healing fractures requires BMP2. The human Bmp2 gene also has been linked to osteoporosis and osteoarthritis. In addition, all forms of pathological calcification in the vasculature and in cardiac valves involve the pro-osteogenic BMP2. The diverse tissues, mechanisms, and diseases influenced by BMP2 are too numerous to list here (see OMIM: 112261). However, in all BMP2-influenced pathologies, changes in the behavior and differentiation of pluripotent mesenchymal cells are a recurring theme. Consequently, much effort has been devoted to identifying the molecules and conditions that influence BMP2 synthesis and the complex mechanisms that control Bmp2 gene expression. This review begins with an overview of the Bmp2 gene's chromosomal neighborhood and then summarizes and evaluates known regulatory mechanisms and inducers.
Collapse
Affiliation(s)
- Melissa B Rogers
- Department of Microbiology, Biochemistry and Molecular Genetics, Rutgers New Jersey Medical School, Newark, NJ
| | - Tapan A Shah
- Department of Microbiology, Biochemistry and Molecular Genetics, Rutgers New Jersey Medical School, Newark, NJ
| | - Nadia N Shaikh
- Department of Microbiology, Biochemistry and Molecular Genetics, Rutgers New Jersey Medical School, Newark, NJ
| |
Collapse
|
4
|
Pregizer SK, Mortlock DP. Dynamics and cellular localization of Bmp2, Bmp4, and Noggin transcription in the postnatal mouse skeleton. J Bone Miner Res 2015; 30:64-70. [PMID: 25043193 PMCID: PMC4818007 DOI: 10.1002/jbmr.2313] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 12/21/2013] [Revised: 06/20/2014] [Accepted: 07/07/2014] [Indexed: 01/09/2023]
Abstract
Transcription of BMPs and their antagonists in precise spatiotemporal patterns is essential for proper skeletal development, maturation, maintenance, and repair. Nevertheless, transcriptional activity of these molecules in skeletal tissues beyond embryogenesis has not been well characterized. In this study, we used several transgenic reporter mouse lines to define the transcriptional activity of two potent BMP ligands, Bmp2 and Bmp4, and their antagonist, Noggin, in the postnatal skeleton. At 3 to 4 weeks of age, Bmp4 and Noggin reporter activity was readily apparent in most cells of the osteogenic or chondrogenic lineages, respectively, whereas Bmp2 reporter activity was strongest in terminally differentiated cells of both lineages. By 5 to 6 months, activity of the reporters had generally abated; however, the Noggin and Bmp2 reporters remained remarkably active in articular chondrocytes and persisted there indefinitely. We further found that endogenous Bmp2, Bmp4, and Noggin transcript levels in postnatal bone and cartilage mirrored the activity of their respective reporters in these tissues. Finally, we found that the activity of the Bmp2, Bmp4, and Noggin reporters in bone and cartilage at 3 to 4 weeks could be recapitulated in both osteogenic and chondrogenic culture models. These results reveal that Bmp2, Bmp4, and Noggin transcription persists to varying degrees in skeletal tissues postnatally, with each gene exhibiting its own cell type-specific pattern of activity. Illuminating these patterns and their dynamics will guide future studies aimed at elucidating both the causes and consequences of aberrant BMP signaling in the postnatal skeleton.
Collapse
Affiliation(s)
- Steven K Pregizer
- Center for Human Genetics Research, Department of Molecular Physiology & Biophysics, Vanderbilt University Medical Center, Nashville, TN, USA
| | | |
Collapse
|
5
|
FOTINOS ANASTASIOS, NAGARAJAN NARAYANI, MARTINS ADRIANOS, FRITZ DAVIDT, GARSETTI DIANE, LEE ANNETTET, HONG CHARLESC, ROGERS MELISSAB. Bone morphogenetic protein-focused strategies to induce cytotoxicity in lung cancer cells. Anticancer Res 2014; 34:2095-2104. [PMID: 24778011 PMCID: PMC4791537] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/03/2023]
Abstract
BACKGROUND High bone morphogenetic protein (BMP)-2 expression in lung carcinoma correlates with poor patient prognosis. The present study explored strategies to repress BMP signaling. MATERIALS AND METHODS The cytotoxicity of BMP2-knockdown, dorsomorphin derivatives, and microRNAs was tested in transformed and non-transformed lung cells. Microarray analyses of 1,145 microRNAs in A549 lung adenocarcinoma cells and two other transformed lung cell types relative to BEAS-2B bronchial epithelial cells were performed. RESULTS Reduced BMP2 synthesis inhibited A549 cell growth. The dorsomorphin derivative LDN-193189, but not DMH1 or DMH4, was strongly cytotoxic towards A549 cells, but not towards BEAS-2B cells. Microarray analysis revealed that 106 miRNAs were down-regulated and 69 miRNAs were up-regulated in the three transformed lines. Three down-regulated miRNAs, hsa-mir-34b, hsa-mir-34c-3p, and hsa-miR-486-3p, repressed a BMP2 reporter gene and were cytotoxic in A549 cells, but not towards BEAS-2B cells. CONCLUSION The observed cytotoxicity suggests that reducing BMP signaling is a useful line of attack for therapy of lung cancer.
Collapse
Affiliation(s)
- ANASTASIOS FOTINOS
- Biochemistry and Molecular Biology, Rutgers – NJ Medical School, Newark, NJ, U.S.A
| | - NARAYANI NAGARAJAN
- Biochemistry and Molecular Biology, Rutgers – NJ Medical School, Newark, NJ, U.S.A
| | - ADRIANO S. MARTINS
- Biochemistry and Molecular Biology, Rutgers – NJ Medical School, Newark, NJ, U.S.A
| | - DAVID T. FRITZ
- Biochemistry and Molecular Biology, Rutgers – NJ Medical School, Newark, NJ, U.S.A
| | - DIANE GARSETTI
- Biochemistry and Molecular Biology, Rutgers – NJ Medical School, Newark, NJ, U.S.A
| | - ANNETTE T. LEE
- Center for Genomics and Human Genetics, Feinstein Institute for Medical Research, Manhasset, NY, U.S.A
| | - CHARLES C. HONG
- Division of Cardiovascular Medicine, Vanderbilt University Medical Center, Nashville, TN, U.S.A
| | - MELISSA B. ROGERS
- Biochemistry and Molecular Biology, Rutgers – NJ Medical School, Newark, NJ, U.S.A
| |
Collapse
|
6
|
Marsell R, Steen B, Bais MV, Mortlock DP, Einhorn TA, Gerstenfeld LC. Skeletal trauma generates systemic BMP2 activation that is temporally related to the mobilization of CD73+ cells. J Orthop Res 2014; 32:17-23. [PMID: 24018651 PMCID: PMC4263190 DOI: 10.1002/jor.22487] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 08/21/2013] [Revised: 08/21/2013] [Accepted: 08/21/2013] [Indexed: 02/04/2023]
Abstract
The relationship between BMP2 expression and the recruitment of skeletogenic stem cells was assessed following bone marrow reaming. BMP2 expression was examined using transgenic mice in which β-galactosidase had been inserted into the coding region of BMP2. Stem cell mobilization was analyzed by FACS analysis using CD73, a marker associated with bone marrow stromal stem cells. BMP2 expression was induced in endosteal lining cells, cortical osteocytes and periosteal cells in both the reamed and in contralateral bones. BMP2 mRNA expression in the reamed bone showed an early peak within the first 24 h of reaming followed by a later peak at 7 days, while contralateral bones only showed the 7 days peak of expression. FACS analysis sorting on CD73 positive cells showed a 50% increase of these cells at 3 and 14 days in the marrow of the injured bone and a single peak at 14 days of the marrow cell population of the contralateral bone. A ∼20% increase of CD73 positive cells was seen in the peripheral blood 2 days after reaming. These data showed that traumatic bone injury caused a systemic induction of BMP2 expression and that this increase is correlated with the mobilization of CD73 positive cells.
Collapse
Affiliation(s)
- Richard Marsell
- Department of Orthopaedic Surgery, Boston University Medical Center715 Albany Street, R-205, Boston, 02118, Massachusetts
| | - Brandon Steen
- Department of Orthopaedic Surgery, Boston University Medical Center715 Albany Street, R-205, Boston, 02118, Massachusetts
| | - Manish V Bais
- Department of Orthopaedic Surgery, Boston University Medical Center715 Albany Street, R-205, Boston, 02118, Massachusetts
| | - Douglas P Mortlock
- Department of Molecular Physiology and Biophysics Center for Human Genetics Research, Vanderbilt University School of MedicineNashville, Tennessee
| | - Thomas A Einhorn
- Department of Orthopaedic Surgery, Boston University Medical Center715 Albany Street, R-205, Boston, 02118, Massachusetts
| | - Louis C Gerstenfeld
- Department of Orthopaedic Surgery, Boston University Medical Center715 Albany Street, R-205, Boston, 02118, Massachusetts
| |
Collapse
|
7
|
Kruithof BPT, Xu J, Fritz DT, Cabral CS, Gaussin V, Rogers MB. An in vivo map of bone morphogenetic protein 2 post-transcriptional repression in the heart. Genesis 2011; 49:841-50. [PMID: 21504044 DOI: 10.1002/dvg.20757] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/01/2011] [Revised: 03/08/2011] [Accepted: 04/11/2011] [Indexed: 11/07/2022]
Abstract
The Bmp2 3'untranslated region (UTR) sequence bears a sequence conserved between mammals and fishes that can post-transcriptionally activate or repress protein synthesis. We developed a map of embryonic cells in the mouse where this potent Bmp2 regulatory sequence functions by using a lacZ reporter transgene with a 3'UTR bearing two loxP sites flanking the ultra-conserved sequence. Cre-recombinase-mediated deletion of the ultra-conserved sequence caused strong ectopic expression in proepicardium, epicardium and epicardium-derived cells (EPDC) and in tissues with known epicardial contributions (coronary vessels and valves). Transient transfections of reporters in the epicardial/mesothelial cell (EMC) line confirmed this repression. Ectopic expression of the recombined transgene also occurred in the aorta, outlet septum, posterior cardiac plexus, cardiac and extracardiac nerves and neural ganglia. Bmp2 is dynamically regulated in the developing heart. 3'UTR-mediated mechanisms that restrain BMP2 synthesis may be relevant to congenital heart and vasculature malformations and to adult diseases involving aberrant BMP2 synthesis.
Collapse
MESH Headings
- 3' Untranslated Regions
- Animals
- Bone Morphogenetic Protein 2/genetics
- Bone Morphogenetic Protein 2/metabolism
- Cell Line
- Conserved Sequence
- Embryo, Mammalian/cytology
- Embryo, Mammalian/metabolism
- Embryo, Mammalian/physiology
- Embryonic Development
- Gene Expression Regulation, Developmental
- Genes, Reporter
- Heart/embryology
- Heart/innervation
- Heart/physiology
- Immunohistochemistry
- Integrases/metabolism
- Lac Operon
- Mice
- Mice, Inbred C57BL
- Mice, Transgenic/genetics
- Mice, Transgenic/metabolism
- Neurofilament Proteins/genetics
- Neurofilament Proteins/metabolism
- Pericardium/cytology
- Pericardium/embryology
- Pericardium/metabolism
- Pericardium/physiology
- Protein Processing, Post-Translational
- Rats
- Regulatory Sequences, Nucleic Acid
- Sequence Deletion
- Transcription, Genetic
- Transfection
- Transgenes
Collapse
Affiliation(s)
- Boudewijn P T Kruithof
- Department of Cell Biology, University of Medicine and Dentistry (UMDNJ)-New Jersey Medical School (NJMS), Newark, New Jersey, USA
| | | | | | | | | | | |
Collapse
|